These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2850750)

  • 1. Role of animal and human pharmacology in antifungal drug design.
    Cauwenbergh G; Van Cutsem J
    Ann N Y Acad Sci; 1988; 544():264-9. PubMed ID: 2850750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The triazole antifungal agents: a review of itraconazole and fluconazole.
    Bailey EM; Krakovsky DJ; Rybak MJ
    Pharmacotherapy; 1990; 10(2):146-53. PubMed ID: 2161523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin kinetics of azole antifungal drugs.
    Cauwenbergh G
    Curr Top Med Mycol; 1992; 4():88-136. PubMed ID: 1310076
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J; Van Peer A; Lavrijsen K; Meuldermans W; Woestenborghs R; Cauwenbergh G
    Br J Clin Pract Suppl; 1990 Sep; 71():50-6. PubMed ID: 1965419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.
    Liu L; Bello A; Dresser MJ; Heald D; Komjathy SF; O'Mara E; Rogge M; Stoch SA; Robertson SM
    J Clin Pharmacol; 2016 Feb; 56(2):143-51. PubMed ID: 26044116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P; Joly V; Saint-Julien L; Gillardin JM; Carbon C; Yeni P
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects.
    Van Peer A; Woestenborghs R; Heykants J; Gasparini R; Gauwenbergh G
    Eur J Clin Pharmacol; 1989; 36(4):423-6. PubMed ID: 2544431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of itraconazole by alveolar macrophages.
    Perfect JR; Savani DV; Durack DT
    Antimicrob Agents Chemother; 1993 Apr; 37(4):903-4. PubMed ID: 8388205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity.
    Lim SG; Sawyerr AM; Hudson M; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 1993 Jun; 7(3):317-21. PubMed ID: 8117350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Itraconazole concentrations in airway fluid and tissue.
    Watkins DN; Badcock NR; Thompson PJ
    Br J Clin Pharmacol; 1992 Feb; 33(2):206-7. PubMed ID: 1312855
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical pharmacokinetics of itraconazole: an overview.
    Heykants J; Van Peer A; Van de Velde V; Van Rooy P; Meuldermans W; Lavrijsen K; Woestenborghs R; Van Cutsem J; Cauwenbergh G
    Mycoses; 1989; 32 Suppl 1():67-87. PubMed ID: 2561187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole released for blastomycosis and histoplasmosis therapy.
    Clin Pharm; 1993 Jan; 12(1):6-7. PubMed ID: 8381341
    [No Abstract]   [Full Text] [Related]  

  • 14. Itraconazole.
    Med Lett Drugs Ther; 1993 Jan; 35(888):7-9. PubMed ID: 8380485
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetic profile of orally administered itraconazole in human skin.
    Cauwenbergh G; Degreef H; Heykants J; Woestenborghs R; Van Rooy P; Haeverans K
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):263-8. PubMed ID: 2831254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azole antifungal agents.
    Bodey GP
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal agents. Part II. The azoles.
    Terrell CL
    Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation of oral antifungal therapy.
    Schäfer-Korting M
    Clin Pharmacokinet; 1993 Oct; 25(4):329-41. PubMed ID: 8261715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Itraconazole in systemic fungal infections].
    Denning DW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():3-4. PubMed ID: 1663203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.